Clinical Trial Results:
            A six week randomized, double-blind, multi-center, placebocontrolled, exploratory, adaptive design study to explore the antidepressant properties of the p38 MAP kinase inhibitor GW856553 compared to placebo in adult subjects with Major Depressive Disorder.
    
|     Summary | |
|     EudraCT number | 2009-011200-39 | 
|     Trial protocol | DE EE BG | 
|     Global completion date | 
                                    07 Jul 2010
                             | 
|     Paediatric regulatory details | |
|     Is the trial part of an agreed EMA paediatric investigation plan? | 
                                        No
                                 | 
|     Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Results information | |
|     Results version number | v1(current) | 
|     This version publication date | 
                                    12 Feb 2016
                             | 
|     First version publication date | 
                                    13 Nov 2014
                             | 
|     Other versions | |
|     Summary report(s) | 113009-Clinical-Study-Result-Summary | 
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.    
 
				
